Latest Reports

The “2025 Presbyopia Correction Market Report” offers a detailed analysis of the global market for surgical and pharmaceutical presbyopia treatments and forecasts market performance through 2030. It includes regional and global market sizing, identification of key trends, and discussion of the factors most likely to shape future growth.

This report examines procedure volumes, estimates serviceable patient populations, and forecasts the presbyopia markets for laser vision correction procedures (LASIK, lenticule extraction, and surface ablation), presbyopia-correcting IOLs (PC-IOLs), and pharmaceutical drops by region through 2030.

The report is designed for industry stakeholders—manufacturers, market analysts, ophthalmologists, optometrists, and investors—seeking a clear and actionable view of the presbyopia correction market and its potential over the next five years.

Market Scope’s "2025 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Market Scope’s “2025 European Five Ophthalmic Market Report” dives into Western Europe’s top five ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—exploring 11 ophthalmic submarkets with insights on crucial trends and factors for success. The report reviews current market landscapes, projects market performance through 2030, forecasts disease prevalence, analyzes treatment volumes, and reviews emerging technologies and profiles key competitors. 

The “2024 Ophthalmic Landscape Report” offers a high-level analysis of the ophthalmic market by region and subspecialty and forecasts market performance of nine product categories through 2029. The report analyzes important trends, reviews key factors for future success, comprehensively details the competitive landscape in ophthalmology, and compares the ophthalmic sector across health care and other related markets. 

The “2025 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2030 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and Rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 25 glaucoma pharmaceutical companies are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 Ophthalmic Laser Market Report” offers a comprehensive analysis of the global market for ophthalmic lasers, as well as a discussion of important trends and key factors shaping future success. The report covers photocoagulation, photodisruption, and SLT lasers with market data for 2023 and forecasts through 2029. Product demand is forecast in units and dollars, and market share is analyzed by product category.  Seventeen market competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

This report is designed for ophthalmic industry manufacturers, market analysts, providers, and investors who are interested in the ophthalmic lasers business and related products. In-depth topics include laser treatment estimates, ophthalmic surgeons using lasers, and manufacturers of ophthalmic lasers (excluding femtosecond and excimer lasers). 

The “2025 Retinal Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2024 market and forecasts market growth and evolution through 2029. Additionally, 19 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook. 

Market Scope’s "2024 Corneal Disease Model" offers extensive country-level prevalence data and five-year forecasts for nine corneal diseases for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Market Scope’s "2024 Retinal Disease Model" offers extensive country-level prevalence data and five-year forecasts for retinal diseases and conditions by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2024 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.